|  | | | | |
| Company | Gattefossé | Gattefossé | Gattefossé | Gattefossé | Gattefossé |
| Item | Tefose® 63 | Gelucire® 43/01 | Gelucire® 44/14 | Labrafil® M 2125 CS | LauroglycolTM 90 |
| Citations | | | | | |
| Price | | | | | |
| Vendor Product Page | Company Product Page | Company Product Page | Company Product Page | Company Product Page | Company Product Page |
| Description | PEG-6 stearate (Type I) NF and Ethylene glycol palmitostearate EP/NF/JPE and PEG-32 stearate (Type I) NF | Hard fat NF/EP/JPE | Lauroyl polyoxyl-32 glycerides NF / Lauroyl macrogol-32 glycerides EP / Lauroyl macrogolglycerides (32) Ch P | Linoleoyl polyoxyl-6 glycerides NF / Linoleoyl macrogol-6 glycerides EP | Propylene glycol monolaurate (Type II) NF/EP |
| Final Dosage Form | Creams, lotions, ointments | Capsules, creams, lotions, ointments | Capsules, emulsions, suspensions | Capsules, emulsions, suspensions, creams, lotions, ointments | Capsules, emulsions, suspensions, creams, lotions, ointments |
| Functionality | Non-ionic O/W emulsifier, low-energy one-pot processing, high mucosal tolerance | Matrix-forming agent for protection of APIs sensitive to oxidation, humidity, or light, consistency agent in oral and topical formulations | Solubilizer, bioavailability enhancer, and surfactant in solid dispersions and SMEDDS | Solubilizer and bioavailability enhancer for poorly-soluble APIs, self-emulsifier in aqueous fluid | Solubilizer, bioavailability and penetration enhancer, water insoluble W/O co-surfactant for SELF and suspensions |
| Pharmacopeial Compliance | Yes | Yes | Yes | Yes | Yes |
| Type | Block | Pellets | Block | Liquid | Liquid |
| Application | Topical, Rectal/Vaginal | Oral, Topical | Oral | Oral, Topical, Rectal/Vaginal, Transdermal, Nasal, Parenteral | Oral, Topical, Transdermal |
| Get quote | | | | | |